Molecule Details
InChIKeyRYIDHLJADOKWFM-MAODMQOUSA-N
Compound NameSamidorphan
Canonical SMILESNC(=O)c1ccc2c(c1O)[C@]13CCN(CC4CC4)[C@H](C2)[C@]1(O)CCC(=O)C3
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Homologous
Avg pChEMBL9.5
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB12543
Drug NameSamidorphan
CAS Number852626-89-2
Groups approved investigational
ATC Codes N05AH53
Description[Olanzapine] is an effective atypical antipsychotic that, like other antipsychotics, is associated with weight gain, metabolic dysfunction, and increased risk of type II diabetes.[A235638, A235643] Samidorphan is a novel opioid antagonist structurally related to [naltrexone], with a higher affinity ...

Categories: Alkaloids Antipsychotic Agents Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 Substrates Diazepines, Oxazepines, Thiazepines and Oxepines Heterocyclic Compounds, Fused-Ring Morphinans Nervous System Opiate Alkaloids Opioid Antagonists Peripheral Nervous System Agents Phenanthrenes Psycholeptics Sensory System Agents
Cross-references: BindingDB: 50165049 CHEMBL426084 ChemSpider: 23259667 PubChem:11667832 PubChem:347828769 RxCUI: 2559612 Wikipedia: Samidorphan ZINC: ZINC000028478244
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P35372 OPRM1 Homo sapiens Human PF00001 10.3 Ki ChEMBL;BindingDB
P41145 OPRK1 Homo sapiens Human PF00001 9.6 Ki ChEMBL;BindingDB
P41143 OPRD1 Homo sapiens Human PF00001 8.6 Ki ChEMBL;BindingDB
DrugBank Target Actions (8)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10632 CYP2C8 Cytochrome P450 2C8 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P35372 OPRM1 Mu-type opioid receptor antagonist targets
P35372 OPRM1 Mu-type opioid receptor inhibitor targets
P41143 OPRD1 Delta-type opioid receptor partial agonist targets
P41145 OPRK1 Kappa-type opioid receptor partial agonist targets